Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Belite Bio, Inc - American Depositary Shares (NQ:BLTE)

165.87 +1.76 (+1.07%)
Streaming Delayed Price Updated: 1:09 PM EDT, Mar 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Belite Bio, Inc - American Depositary Shares

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Expert Ratings for Belite Bio ↗
 
Via Benzinga
News headline image
Belite Bio to Participate in the Benchmark Company’s Upcoming Discovery One-on-One Investor Conference
From Belite Bio, Inc
Via GlobeNewswire
News headline image
Belite Bio to Participate in the BTIG Ophthalmology Day
From Belite Bio, Inc
Via GlobeNewswire
News headline image
Belite Bio Reports Third Quarter 2023 Operational Highlights and Financial Results
From Belite Bio, Inc
Via GlobeNewswire
News headline image
Expert Ratings for Belite Bio ↗
 
Via Benzinga
News headline image
The Latest Analyst Ratings for Belite Bio ↗
 
Via Benzinga
News headline image
Analyst Expectations for Belite Bio's Future ↗
 
Via Benzinga
News headline image
Deutsche Bank ADR Investor Conference: Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Belite Bio to Host Webcast on November 14, 2023, to Discuss Third Quarter 2023 Financial Results
From Belite Bio, Inc
Via GlobeNewswire
News headline image
Why Shares of Belite Bio Are Slumping Wednesday ↗
The biopharmaceutical company announced a stock sale that's not great news to current investors. 
Via The Motley Fool
News headline image
Belite Bio, Inc. to present at the Deutsche Bank ADR Virtual Investor Conference on 8 November 2023
Company invites individual and institutional investors, as well as advisors, to attend interactive, real-time virtual event 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Belite Bio Presents Results from a 24-month, Phase 2 Study of Tinlarebant in Childhood-onset Stargardt Disease at the AAO Annual Meeting
From Belite Bio, Inc
Via GlobeNewswire
News headline image
International companies to host live webcasts at Deutsche Bank’s Depositary Receipts
Virtual Investor Conference on November 8th and 9th, 2023 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Belite Bio Announces Presentation at the American Academy of Ophthalmology 2023 Annual Meeting
From Belite Bio, Inc
Via GlobeNewswire
News headline image
Why 22nd Century Group Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Gainers Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) shares jumped 283.7% to $1.3007 after Harmony Biosciences entered into definitive agreement to acquire the company for total potential consideration... 
Via Benzinga
News headline image
Belite Bio Reports Second Quarter 2023 Operational Highlights and Financial Results
From Belite Bio, Inc
Via GlobeNewswire
News headline image
Belite Bio to Host Webcast on August 9, 2023 to Discuss Second Quarter 2023 Financial Results
From Belite Bio, Inc
Via GlobeNewswire
News headline image
Belite Bio Doses First Subject in Pivotal Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant for GA
From Belite Bio, Inc
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2023 ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2023 ↗
 
Via Benzinga
News headline image
Belite Bio Completes Enrollment in Pivotal Global Phase 3 DRAGON Trial Evaluating Oral Tinlarebant for Stargardt Disease
From Belite Bio, Inc
Via GlobeNewswire
News headline image
Why Shares of Belite Bio Soared This Week ↗
The clinical-stage biotech company bounced back from a 52-week low late last week. 
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
Why Carnival Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Gainers Benitec Biopharma Inc. (NASDAQ: BNTC) climbed 104% to $0.4050 after the company announced it received FDA clearance of the IND for BB-301 for the treatment of Oculopharyngeal Muscular... 
Via Benzinga
News headline image
Wolfspeed, Genesco, PacWest Bancorp And Other Big Stocks Moving Higher On Monday ↗
U.S. stocks traded mixed, with the Nasdaq Composite gaining around 60 points on Monday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
  Friday's session saw 32 companies set new 52-week lows. 
Via Benzinga
News headline image
Top 5 Health Care Stocks That Are Set To Fly In Q2 ↗
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Why Capri Holdings Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) shares jumped 143% to $0.45 after the company announced it received agreement from the FDA on its proposed single confirmatory Phase 3 study of... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.